3.74BMarket Cap-13.32P/E (TTM)
35.080High32.290Low1.49MVolume32.980Open34.380Pre Close51.20MTurnover1.49%Turnover RatioLossP/E (Static)108.08MShares36.60052wk High4.45P/B3.47BFloat Cap13.48052wk Low--Dividend TTM100.04MShs Float193.540Historical High--Div YieldTTM8.12%Amplitude13.480Historical Low34.454Avg Price1Lot Size
Zai Lab Stock Forum
Zai Lab (NASDAQ: ZLAB; HKEX: 9688) has received Orphan Drug Designation (ODD) from the U.S. FDA for ZL-1310, their first-in-class DLL3 antibody-drug conjugate (ADC) designed to treat small cell lung cancer (SCLC). The designation comes after promising results from an ongoing Phase 1a/1b study in patients with previously treated extensive-stage SCL...
No comment yet